GlassScriptPhysician profile
James D Majors
NPI 1699875963
$2,529.44
in general payments reported to CMS, 2019-2025
27 companies · $1,394 in 2025
The $1,394 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $55.09 · 2021: $70.93 · 2022: $107 · 2023: $294 · 2024: $253 · 2025: $1,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237 · Travel and Lodging: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.87 |
| Travel and Lodging | $703.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,129.08 | 2025 | |
| Tesaro, INC. | $206.77 | 2019 | |
| Organogenesis INC. | $124.98 | 2023 | Puraply Antimicrobial |
| Davol INC. | $110.06 | 2019-2023 | Phasix Mesh |
| Smith+Nephew, INC. | $107.00 | 2021-2024 | Collagenase Santyl, Renasys Go V2 Home |
| Solventum Corporation | $79.83 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Lifenet Health | $76.75 | 2025 | Theragenesis Wound Matrix |
| Merck Sharp & Dohme LLC | $65.38 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $62.30 | 2023-2024 | Nuzyra |
| Myriad Genetic Laboratories, INC. | $62.29 | 2021-2024 | Bracanalysis Cdx, Myrisk |
| Clovis Oncology, INC. | $52.38 | 2019 | |
| Polynovo North America LLC | $45.80 | 2025 | Novosorb Btm |
| Elucent Medical | $44.00 | 2024 | |
| Conmed Corporation | $41.05 | 2022-2025 | Airseal |
| Molnlycke Health Care US, LLC | $40.28 | 2022-2024 | Mepilex Border Sacrum, Mepilex Border Flex, Exufiber Ag+ |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $34.96 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Baxter Healthcare | $34.55 | 2022-2023 | Seprafilm |
| Next Science LLC | $33.85 | 2023 | Xperience, Blastx, Surgx |
| Kerecis Limited | $31.79 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Sanofi Pasteur INC. | $25.89 | 2025 | |
| Astellas Pharma US INC | $24.51 | 2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $19.17 | 2025 | Gattex |
| Acera Surgical, INC. | $17.91 | 2024 | Restrata Wound Matrix |
| Abbvie INC. | $17.55 | 2019 | |
| Hydrofera LLC | $14.33 | 2022 | |
| Heron Therapeutics, INC. | $14.15 | 2025 | Zynrelef |
| Janssen Pharmaceuticals, INC | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Majors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.